The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback